InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (11 ops.)
Discover the full record of transactions filed by Ho Carole, Directeur Médical. Director active across 1 company, notably Denali Therapeutics Inc.. In total, 13 filings have been published. Breakdown: 0 buy · 11 sells. Total volume traded: €1.1m. History available since 19 August 2021. The latest transaction was disclosed on 11 February 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations13 total
2,918 shares@ US$34.710.0034% mcap7.7% of flowCommon StockSEC:0001714899-22-000039:0
1,423 shares@ US$37.09870.0018% mcap4.0% of flowCommon StockSEC:0001714899-22-000033:0
1,423 shares@ US$37.09870.0018% mcap8.7% of flowCommon StockSEC:0001714899-22-000033
2,845 shares@ US$44.780.0044% mcap21.3% of flowCommon StockSEC:0001714899-22-000006
2,845 shares@ US$44.780.0044% mcap9.8% of flowCommon StockSEC:0001714899-22-000006:0
31,000 shares0Common StockSEC:0001714899-22-000003
31,000 shares0Common StockSEC:0001714899-22-000003:0
1,476 shares@ US$42.520.0022% mcap10.5% of flowCommon StockSEC:0001714899-21-000115
1,476 shares@ US$42.520.0022% mcap4.8% of flowCommon StockSEC:0001714899-21-000115:0
6,143 shares@ US$48.910.0099% mcap48.3% of flowCommon StockSEC:0001714899-21-000088
6,143 shares@ US$48.910.0099% mcap22.3% of flowCommon StockSEC:0001714899-21-000088:0
1,402 shares@ US$49.310.0023% mcap11.2% of flowCommon StockSEC:0001714899-21-000087
1,402 shares@ US$49.310.0023% mcap5.2% of flowCommon StockSEC:0001714899-21-000087:0
13 of 13 declarations
About Ho Carole
Carole Ho is the Chief Medical Officer at Denali Therapeutics Inc. She is responsible for the medical strategy and clinical research of the company. Her expertise in biotechnology is essential for the development of innovative treatments and for leading clinical trials.
